Inogen Q2 2024 Adj. EPS $(0.07) Beats $(0.55) Estimate, Sales $88.765M Beat $82.500M Estimate
Portfolio Pulse from Benzinga Newsdesk
Inogen (NASDAQ: INGN) reported Q2 2024 adjusted EPS of $(0.07), significantly beating the analyst estimate of $(0.55). The company also reported sales of $88.765 million, surpassing the $82.500 million estimate and marking a 6.13% increase from the same period last year.
August 06, 2024 | 9:44 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Inogen reported better-than-expected Q2 2024 results with an adjusted EPS of $(0.07) beating the $(0.55) estimate and sales of $88.765 million surpassing the $82.500 million estimate. This indicates strong performance and could positively impact the stock price in the short term.
The significant beat on both EPS and sales estimates suggests strong operational performance. The 6.13% YoY sales increase further supports a positive outlook. Investors are likely to react favorably, driving the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100